All Stories

  1. Agonism of Histaminergic-H1 Receptors in Ischemic Postconditioning During Cerebral Ischemia-Reperfusion Injury is Protective

    Article • Current Neurovascular Research, February 2021, Bentham Science Publishers

    Associate Professor Bhupesh Sharma

  2. Neuroprotective Effects of Nicorandil in Chronic Cerebral Hypoperfusion-Induced Vascular Dementia

    Article • Journal of Stroke and Cerebrovascular Diseases, November 2016, Elsevier

    Associate Professor Bhupesh Sharma

  3. Effect of ruthenium red, a ryanodine receptor antagonist in experimental diabetes induced vascular endothelial dysfunction and associated dementia in rats

    Article • Physiology & Behavior, October 2016, Elsevier

    Associate Professor Bhupesh Sharma

  4. Selective Modulator of Cannabinoid Receptor Type 2 Reduces Memory Impairment and Infarct Size During Cerebral Hypoperfusion and Vascular Dementia

    Article • Current Neurovascular Research, September 2016, Bentham Science Publishers

    Associate Professor Bhupesh Sharma

  5. Selective modulator of cannabinoid receptor type 2 (CB2) against biochemical alterations and brain damage in chronic cerebral hypoperfusion induced vascular dementia

    Article • Current Neurovascular Research, September 2016, Bentham Science Publishers

    Associate Professor Bhupesh Sharma

  6. Protective effect of transient receptor potential vanilloid subtype 1 (TRPV1) modulator, against behavioral, biochemical and structural damage in experimental models of Alzheimer's disease

    Article • Brain Research, July 2016, Elsevier

    Associate Professor Bhupesh Sharma

  7. Antagonism of Endothelin (ETA and ETB) Receptors During Renovascular Hypertension-Induced Vascular Dementia Improves Cognition

    Article • Current Neurovascular Research, June 2016, Bentham Science Publishers

    Associate Professor Bhupesh Sharma

  8. Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats

    Article • Brain Research Bulletin, June 2016, Elsevier

    Associate Professor Bhupesh Sharma

  9. Selective Serotonin-norepinephrine Re-uptake Inhibition Limits Renovas-cular-hypertension Induced Cognitive Impairment, Endothelial Dysfunction, and Oxidative Stress Injury

    Article • Current Neurovascular Research, March 2016, Bentham Science Publishers

    Associate Professor Bhupesh Sharma

  10. Reversal in Cognition Impairments, Cholinergic Dysfunction, and Cerebral Oxidative Stress Through the Modulation of Ryanodine Receptors (RyRs) and Cysteinyl Leukotriene-1 (CysLT1) Receptors

    Article • Current Neurovascular Research, January 2016, Bentham Science Publishers

    Associate Professor Bhupesh Sharma

  11. Calcium Channel Blockade and Peroxisome Proliferator Activated Receptor ? Agonism Diminish Cognitive Loss and Preserve Endothelial Function During Diabetes Mellitus

    Article • Current Neurovascular Research, January 2016, Bentham Science Publishers

    Associate Professor Bhupesh Sharma

  12. Pharmacological benefits of selective modulation of cannabinoid receptor type 2 (CB2) in experimental Alzheimer's disease

    Article • Pharmacology Biochemistry and Behavior, January 2016, Elsevier

    Associate Professor Bhupesh Sharma

  13. Minocycline ameliorates prenatal valproic acid induced autistic behaviour, biochemistry and blood brain barrier impairments in rats

    Article • Brain Research, January 2016, Elsevier

    Associate Professor Bhupesh Sharma

  14. Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder

    Article • Neurochemistry International, December 2015, Elsevier

    Associate Professor Bhupesh Sharma

  15. Neuroprotective effect of selective DPP-4 inhibitor in experimental vascular dementia

    Article • Physiology & Behavior, December 2015, Elsevier

    Associate Professor Bhupesh Sharma

  16. Neuroprotective Effects of Agomelatine and Vinpocetine Against Chronic Cerebral Hypoperfusion Induced Vascular Dementia

    Article • Current Neurovascular Research, July 2015, Bentham Science Publishers

    Associate Professor Bhupesh Sharma

  17. Melatonin receptor and KATP channel modulation in experimental vascular dementia

    Article • Physiology & Behavior, April 2015, Elsevier

    Associate Professor Bhupesh Sharma

  18. Efficacy of bosentan, a dual ETA and ETB endothelin receptor antagonist, in experimental diabetes induced vascular endothelial dysfunction and associated dementia in rats

    Article • Pharmacology Biochemistry and Behavior, September 2014, Elsevier

    Associate Professor Bhupesh Sharma

  19. In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator

    Article • Psychopharmacology, July 2014, Springer Science + Business Media

    Associate Professor Bhupesh Sharma

  20. Pharmacological benefits of agomelatine and vanillin in experimental model of Huntington's disease

    Article • Pharmacology Biochemistry and Behavior, July 2014, Elsevier

    Associate Professor Bhupesh Sharma

  21. Protective effects of phosphodiesterase-1 (PDE1) and ATP sensitive potassium (KATP) channel modulators against 3-nitropropionic acid induced behavioral and biochemical toxicities in experimental Huntington׳s disease

    Article • European Journal of Pharmacology, June 2014, Elsevier

    Associate Professor Bhupesh Sharma

  22. Modulation of Transient Receptor Potential Vanilloid Subtype 1 (TRPV1) and Norepinephrine Transporters (NET) Protect Against Oxidative Stress, Cellular Injury, and Vascular Dementia

    Article • Current Neurovascular Research, May 2014, Bentham Science Publishers

    Associate Professor Bhupesh Sharma

  23. Pharmacological benefit of I1-imidazoline receptors activation and nuclear factor kappa-B (NF-κB) modulation in experimental Huntington's disease

    Article • Brain Research Bulletin, March 2014, Elsevier

    Associate Professor Bhupesh Sharma

  24. Pharmacological modulation of I1-imidazoline and α2-adrenoceptors in sub acute brain ischemia induced vascular dementia

    Article • European Journal of Pharmacology, January 2014, Elsevier

    Associate Professor Bhupesh Sharma

  25. Arsenic toxicity induced endothelial dysfunction and dementia: Pharmacological interdiction by histone deacetylase and inducible nitric oxide synthase inhibitors

    Article • Toxicology and Applied Pharmacology, November 2013, Elsevier

    Associate Professor Bhupesh Sharma

  26. Pharmacological inhibition of inducible nitric oxide synthase (iNOS) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, convalesce behavior and biochemistry of hypertension induced vascular dementia in rats

    Article • Pharmacology Biochemistry and Behavior, February 2013, Elsevier

    Associate Professor Bhupesh Sharma

  27. Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type: possible involvement of PPAR-  agonistic property

    Article • Journal of the Renin-Angiotensin-Aldosterone System, October 2012, SAGE Publications

    Associate Professor Bhupesh Sharma

  28. Salutary effect of NFκB inhibitor and folacin in hyperhomocysteinemia–hyperlipidemia induced vascular dementia

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, August 2012, Elsevier

    Associate Professor Bhupesh Sharma

  29. Experimental hypertension induced vascular dementia: Pharmacological, biochemical and behavioral recuperation by angiotensin receptor blocker and acetylcholinesterase inhibitor

    Article • Pharmacology Biochemistry and Behavior, July 2012, Elsevier

    Associate Professor Bhupesh Sharma

  30. Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA–salt hypertension-induced vascular dementia in rats

    Article • Psychopharmacology, April 2012, Springer Science + Business Media

    Associate Professor Bhupesh Sharma

  31. Behavioral and biochemical investigations to explore pharmacological potential of PPAR-gamma agonists in vascular dementia of diabetic rats

    Article • Pharmacology Biochemistry and Behavior, December 2011, Elsevier

    Associate Professor Bhupesh Sharma

  32. Pharmacological investigations on potential of peroxisome proliferator-activated receptor-gamma agonists in hyperhomocysteinemia-induced vascular dementia in rats

    Article • Neuroscience, September 2011, Elsevier

    Associate Professor Bhupesh Sharma

  33. Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats

    Article • Psychopharmacology, January 2011, Springer Science + Business Media

    Associate Professor Bhupesh Sharma

  34. Pitavastatin and 4-Hydroxy-3-Methoxyacetophenone (HMAP) Reduce Cognitive Dysfunction in Vascular Dementia During Experimental Diabetes

    Article • Current Neurovascular Research, August 2010, Bentham Science Publishers

    Associate Professor Bhupesh Sharma

  35. Beneficial Effects of Donepezil on Vascular Endothelial Dysfunction-Associated Dementia Induced by L-Methionine in Rats

    Article • JOURNAL OF HEALTH SCIENCE, January 2009, Pharmaceutical Society of Japan

    Associate Professor Bhupesh Sharma

  36. Exploitation of HIV protease inhibitor Indinavir as a memory restorative agent in experimental dementia

    Article • Pharmacology Biochemistry and Behavior, June 2008, Elsevier

    Associate Professor Bhupesh Sharma

  37. Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil

    Article • Journal of Psychopharmacology, January 2008, SAGE Publications

    Associate Professor Bhupesh Sharma

  38. Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats

    Article • BMC Pharmacology, January 2008, Springer Science + Business Media

    Associate Professor Bhupesh Sharma